Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2021
Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial
Adam B Murphy, Michael R Abern, Li Liu, et al.
The Journal of Urology
|
October 26, 2020
Performance of Prostate Health Index in Biopsy Naïve Black Men
Rilwan Babajide, Samuel Carbunaru, Oluwarotimi S Nettey, et al.
Biology
|
May 24, 2024
1,25-Dihydroxyvitamin D<sub>3</sub> Suppresses Prognostic Survival Biomarkers Associated with Cell Cycle and Actin Organization in a Non-Malignant African American Prostate Cell Line
Jabril R Johnson, Rachel N Martini, Yate-Ching Yuan, et al.
BJUI Compass
|
April 27, 2022
Performance of prostate health index and PSA density in a diverse biopsy-naïve cohort with mpMRI for detecting significant prostate cancer
Samuel Carbunaru, James Stinson, Rilwan Babajide, et al.
The Journal of Urology
|
March 23, 2026
Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRI
Marina Schnauss, Nicole Handa, Ramin Nateghi, et al.
Cancer Medicine
|
October 3, 2023
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial
Samuel Carbunaru, Zequn Sun, Cordero McCall, et al.
Urologic Oncology
|
September 22, 2018
Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors
Oluwarotimi S Nettey, Austin J Walker, Mary Kate Keeter, et al.
European Urology
|
April 3, 2022
Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care
Yaw A Nyame, Matthew R Cooperberg, Marcus G Cumberbatch, et al.
The Journal of Urology
|
April 9, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial
Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
The Journal of Urology
|
July 8, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: Erratum
Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2021
Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial
Adam B Murphy, Michael R Abern, Li Liu, et al.
The Journal of Urology
|
October 26, 2020
Performance of Prostate Health Index in Biopsy Naïve Black Men
Rilwan Babajide, Samuel Carbunaru, Oluwarotimi S Nettey, et al.
Biology
|
May 24, 2024
1,25-Dihydroxyvitamin D<sub>3</sub> Suppresses Prognostic Survival Biomarkers Associated with Cell Cycle and Actin Organization in a Non-Malignant African American Prostate Cell Line
Jabril R Johnson, Rachel N Martini, Yate-Ching Yuan, et al.
BJUI Compass
|
April 27, 2022
Performance of prostate health index and PSA density in a diverse biopsy-naïve cohort with mpMRI for detecting significant prostate cancer
Samuel Carbunaru, James Stinson, Rilwan Babajide, et al.
The Journal of Urology
|
March 23, 2026
Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRI
Marina Schnauss, Nicole Handa, Ramin Nateghi, et al.
Cancer Medicine
|
October 3, 2023
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial
Samuel Carbunaru, Zequn Sun, Cordero McCall, et al.
Urologic Oncology
|
September 22, 2018
Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors
Oluwarotimi S Nettey, Austin J Walker, Mary Kate Keeter, et al.
European Urology
|
April 3, 2022
Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care
Yaw A Nyame, Matthew R Cooperberg, Marcus G Cumberbatch, et al.
The Journal of Urology
|
April 9, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial
Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
The Journal of Urology
|
July 8, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: Erratum
Alon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
Page
of 8